Loading company…
Toursun Synbio develops AI tools for protein design and enzyme modification.
Toursun Synbio develops ProteinEngine, an AI protein design platform used in areas including food, medicine, chemicals, and medical aesthetics. Founded in 2023 and based in Shanghai, China, it closed angel funding in February 2024 and an angel+ round in September 2025 from Shanghai Angel Group and Chengmei Capital. The company planned to further develop the platform and expand customer services.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in